entertainment -WSS

entertainment

author：fashion 2025-10-01 17:34:59 - browse：76

Illustration of a person walking across a tightrope, trying to balance. — Adobe

Hospitals are telling government officials it would be illegal to claw back $7.8 billion as part of a remedy that is making hospitals whole over underpaid drug discounts — and they may sue if that plan goes into effect.

The industry is walking a tightrope by trying to maximize the amount of money hospitals can keep. Lobbyists are praising federal officials for agreeing to dole out billions of dollars in future, lump-sum payments, but they are also pressuring Medicare not to offset a penny of those funds.

For several years during the Trump administration, Medicare cut payments for hospitals’ drugs under the federal 340B drug discount program, but the Supreme Court invalidated that policy in 2018. In July, Medicare proposed a solution: Hospitals would get $9 billion to cover what they are owed under the 340B program, but to offset those costs, the government would recoup $7.8 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Pfizer, Moderna say biotech, pharma drug development is a sprint

hotspot

WSS

Mirador, a new biotech startup, launches with $400 million

Hospitals look to new technology to keep health care workers safe

Medical devices makers are asking for forgiveness, not permission

Congress must reauthorize a committee to support older Americans

Surgeons perform first xenotransplant using CRISPR'd pig kidney

David Sabatini, ex

Wikipedia

entertainment

leisure time

After affirmative action ruling, medical educators look to 'holistic review'

CRISPR pioneers react to Casgevy, first gene

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Weight loss drug costs may need more research, senator suggests

Continuity nursing helped my family in our darkest PICU moments

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

What Kate Middleton's cancer revelation might teach the world

After affirmative action ruling, medical educators look to 'holistic review'

A daunting task: navigating dual Medicare, Medicaid eligibility

explore

Mirador, a new biotech startup, launches with $400 million

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

CRISPR technology availability, affordability needs to be expanded

Erich Jarvis studies song birds to learn about human stuttering

Pfizer, Moderna say biotech, pharma drug development is a sprint

Yancopoulos of Regeneron works to expand Dupixent success

leisure time

focus

hotspot

Wikipedia